The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome

International Journal of Radiation Oncology Biology Physics

Volumn 67, Issue 3, 2007, Pages 828-833

  Vance, Waseet ^a   Tucker, Susan L ^a   de Crevoisier, Renaud ^a   Kuban, Deborah A ^a   Cheung, M Rex ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Biopsy; Prostate cancer; PSA; Radiotherapy; Survival

Indexed keywords

ANTIGENS; BIOCHEMISTRY; PATIENT MONITORING; RADIOTHERAPY; TUMORS;

CARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE-SPECIFIC ANTIGEN (PSA);

BIOPSY;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RADIATION DOSE; TREATMENT OUTCOME;

AGED; BIOPSY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 33846811294     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.09.027     Document Type: Article

References (21)

1. Cox J.D., Gallagher M.J., Hammond E.H., et al., American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statements on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. J Clin Oncol 17 (1999) 1155
2. Rosser C.J., Kuban D.A., Levy L.B., et al. Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer. J Urol 168 (2002) 2001-2005
3. Cox J.D., and Kline R.W. The lack of prognostic significance of biopsies after radiotherapy for prostatic cancer. Semin Urol 1 (1983) 237-242
4. Kuban D.A., el-Mahdi A.M., and Schellhammer P. The significance of post-irradiation prostate biopsy with long-term follow-up. Int J Radiat Oncol Biol Phys 24 (1992) 409-414
5. Crook J., Malone S., Perry G., et al. Postradiotherapy prostate biopsies: What do they really mean?. Results for 498 patients. Int J Radiat Oncol Biol Phys 48 (2000) 355-367
6. Pollack A., Zagars G.K., Antolak J.A., et al. Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: Analysis of a prostate cancer randomized radiation dose escalation trial. Int J Radiat Oncol Biol Phys 54 (2002) 677-685
7. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M. D. Anderson Phase III Randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
8. Cheung R., Tucker S.L., Lee A.K., et al. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 993-1002
9. Kaplan E.L., and Meier P. Nonparametric estimation of incomplete observations. J Am Statist Assoc 53 (1958) 457-481
10. Cox D.R. Regression models and life tables. J Royal Statist Soc 34 (1972) 181-220
11. Roach M., Hanks G., Thames H.J., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
12. Pickles T. BCCAPCO: Prostate-specific antigen (PSA) bounce and other fluctuations: Which biochemical relapse definition is least prone to PSA false calls?. An analysis of 2,030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy. Int J Radiat Oncol Biol Phys 64 (2006) 1355-1359
13. Levegrun S., Jackson A., Zelefsky M.J., et al. Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: Pitfalls in deducing radiobiologic parameters for tumors from clinical data. Int J Radiat Oncol Biol Phys 51 (2001) 1064-1080
14. Kestin L.L., Goldstein N.S., Vicini F.A., et al. Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 54 (2002) 107-118
15. Magi-Galluzzi C., Sanderson H., and Epstein J.I. Atypia in nonneoplastic prostate glands after radiotherapy for prostate cancer: Duration of atypia and relation to type of radiotherapy. Am J Surg Pathol 27 (2003) 206-212
16. Bostwick D.G., Egbert B.M., and Fajardo L.F. Radiation injury of the normal and neoplastic prostate. Am J Surg Pathol 6 (1982) 541-551
17. Freiha F.S., and Bagshaw M.A. Carcinoma of the prostate: Results of post-irradiation biopsy. Prostate 5 (1984) 19-25
18. Scardino P.T., Frankel J.M., Wheeler T.M., et al. The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer. J Urol 135 (1986) 510-516
19. Shipley W.U., Desilvio M., Pilepich M.V., et al. Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10. Int J Radiat Oncol Biol Phys 64 (2006) 1162-1167
20. Zhou P., Chen M.H., McLeod D., et al. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol 23 (2005) 6992-6998
21. Pickett B., Kurhanewicz J., Coakley F., et al. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 60 (2004) 1047-1055